Women’s health company Renovia has raised $42.3 million in financing to support clinical trials, product and corporate development and future commercial launches, the company said in a statement.
The funding includes $32.3 million in Series B equity and $10 million in venture debt. An SEC filing in July revealed that the company had raised $25.3 million in equity financing.